A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women

European Journal of Dermatology

Volumn 17, Issue 1, 2007, Pages 37-44

  Tsuboi, Ryoji ^a   Tanaka, Takao ^b   Nishikawa, Tooru ^b   Ueki, Rie ^c   Yamada, Hidekazu ^d   Katsuoka, Kensei ^e   Ogawa, Hideoki ^c   Takeda, Katsuyuki ^f  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TAISHO PHARMACEUTICAL CO LTD   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

^d KINDAI UNIVERSITY NARA HOSPITAL   (Japan)

^e KITASATO UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

1 topical minoxidil; Female androgenetic alopecia; Female pattern hair loss; Non vellus hair count; Placebo controlled trial

Indexed keywords

MINOXIDIL; PLACEBO;

ABNORMAL SENSATION; ADULT; APPLICATION SITE DISCOMFORT; ARTICLE; CLINICAL TRIAL; CONTACT DERMATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DESQUAMATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY HAIR FEELING; ECZEMA; ERYTHEMA; EYE IRRITATION; FEMALE; HAIR GROWTH; HEADACHE; HEART INFARCTION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALAISE; MALE TYPE ALOPECIA; MULTIPLE CYCLE TREATMENT; RANDOMIZED CONTROLLED TRIAL; SCALP PRURITUS; SELF EVALUATION; SKIN IRRITATION; STRANGE FEELING; SYSTEMIC MALAISE;

EID: 33847713689     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Tosti A, Piraccini BM. Androgenetic alopecia. Int J Dermatol 1999; 38: 1-7.
2. Olsen EA. Female pattern hair loss. J Am Acad Dermatol 2001; 45: S70-S80.
3. Levy-Nissenbaum E, Bar-Natan M, Frydman M, Pras E. Confirmation of the association between male pattern baldness and the androgen receptor gene. Eur J Dermatol 2005; 15: 339-40.
4. Van Neste D. Thickness, medullation and growth rate of female scalp hair are subject to significant variation according to pigmentation and scalp location during ageing. Eur J Dermatol 2004; 14: 28-32.
5. Olsen EA. Androgenetic alopecia. In: Olsen EA, ed. Disorders of hair growth: diagnosis and treatment. New York: McGraw-Hill, 1994: 257-83.
6. Hamilton JB. Patterned loss of hair in man: types and incidence. Ann N Y Acad Sci 1951; 53: 708-28.
7. Price VH. Treatment of hair loss. N Engl J Med 1999; 341: 964-73.
8. Hoffmann R, Happle R. Current understanding of androgenetic alopecia. Part II: clinical aspect and treatment. Eur J Dermatol 2000; 10: 410-7.
9. Storer JS, Brzuskiewicz J, Floyd H, Rice JC. Topical minoxidil for male pattern baldness. Am J Med Sci 1986; 291: 328-33.
10. Olsen EA, DeLong ER, Weiner MS. Dose-response study of topical minoxidil in male pattern baldness. J Am Acad Dermatol 1986; 15: 30-7.
11. DeVillez RL. Androgenetic alopecia treated with topical minoxidil. J Am Acad Dermatol 1987; 16: 669-72.
12. Shupack JL, Kassimir JJ, Thirumoorthy T, Reed ML, Jondreau L. Dose-response study of topical minoxidil in male pattern alopecia. J Am Acad Dermatol 1987; 16: 673-6.
13. Savin RC. Use of topical minoxidil in the treatment of male pattern baldness. J Am Acad Dermatol 1987; 16: 696-704.
14. Katz HI, Hien NT, Prawer SE, Goldman SJ. Long-term efficacy of topical minoxidil in male pattern baldness. J Am Acad Dermatol 1987; 16: 711-8.
15. Kreindler TG. Topical minoxidil in early androgenetic alopecia. J Am Acad Dermatol 1987; 16: 718-24.
16. Rushton DH, Unger WP, Cotterill PC, Kingsley P, James KC. Quantitative assessment of 2% topical minoxidil in the treatment of male pattern baldness. Clin Exp Dermatol 1989; 14: 40-6.
17. Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002; 47: 377-85.
18. DeVillez RL, Jacobs JP, Szpunar CA, Warner ML. Androgenetic alopecia in the female. Arch Dermatol 1994; 130: 303-7.
19. Whiting DA, Jacobson C. Treatment of female androgenetic alopecia with minoxidil2%. Int J Dermatol 1992; 31: 800-4.
20. Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, et al. A randomized,placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol 2004; 50: 541-53.
21. Price VH, Menefee E. Quantitative estimation of hair growth I.Androgenetic alopecia in women: Effect of minoxidil. J Invest Dermatol 1990; 95: 683-7.
22. Jacobs JP, Szpunar CA, Warner ML. Use of topical minoxidil therapy for androgenetic alopecia in women. Int J Dermatol 1993; 32: 758-62.
23. Takeda K, Ishibashi Y, Watanabe R, Niimura M, Watanabe Y, Asada Y, et al. Investigation on optimal concentration of topical minoxidil solution in male pattern baldness by double blind study I. J of Clinical Therapeutics and Medicine 1992; 8: 1597-623; (Japanese).
24. Watanabe Y, Takemura T, Sakuma A. Investigation on optimal concentration of topical minoxidil solution in male pattern baldness by double blind study II. Clin Pharmacol Ther 1992; 2: 415-37; (Japanese).
25. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977; 97: 247-54.
26. Kawashima M, Hayashi N, Igarashi A, Kitahara H, Maeguchi M, Mizuno A, et al. Finasteride in the treatment of Japanese men with male pattern hair loss. Eur J Dermatol 2004; 14: 247-54.
27. Rushton DH, James KC, Mortimer CH. The unit area trichogram in the assessment of androgen-dependent alopecia. Br J Dermatol 1983; 109: 429-37.
28. Rushton DH, Ramsay ID, James KC, Norris MJ, Gilkes JJH. Biochemical and trichological characterization of diffuse alopecia in women. Br J Dermatol 1990; 123: 187-97.